Back
INNOVATE Corp. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
26
VATE
INNOVATE Corp.
Last Price:
$4.50
Seasonality Move:
34.63%
Buy
61
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$117.57
Seasonality Move:
-9.01%
Sell
26
INNOVATE Corp. (VATE)
is a Sell
Is INNOVATE Corp. a Buy, Sell or Hold?
-
The current INNOVATE Corp. [VATE] share price is $4.66. The Score for VATE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
VATE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $117.62. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VATE Stock Price Chart
What is INNOVATE Corp.'s stock price today?
-
The INNOVATE Corp. share price today is $4.66Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VATE is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $117.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.
VATE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 38.16 | Sell |
| Chaikin Money Flow: | -22099 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 65.29 | Buy |
| Chaikin Money Flow: | 622990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.54 - 107.68) | Buy |
| Bollinger Bands (100): | (93.66 - 107.58) | Buy |
VATE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.9 | Sell |
| 20-day SMA: | 5.05 | Sell |
| 50-day SMA: | 5.02 | Sell |
| 200-day SMA: | 5.78 | Sell |
| 8-day EMA: | 4.89 | Sell |
| 20-day EMA: | 5.02 | Sell |
| 50-day EMA: | 4.94 | Sell |
| 200-day EMA: | 3.09 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.58 | Buy |
| 20-day SMA: | 104.18 | Buy |
| 50-day SMA: | 104.81 | Buy |
| 200-day SMA: | 81.44 | Buy |
| 8-day EMA: | 107.12 | Buy |
| 20-day EMA: | 105.38 | Buy |
| 50-day EMA: | 103.54 | Buy |
| 200-day EMA: | 86.38 | Buy |
INNOVATE Corp. Earnings Growth & VATE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
INNOVATE Corp. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||